Global Natural Killer (NK) Cell Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Natural Killer (NK) Cell Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Natural Killer (NK) Cell Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Natural Killer (NK) Cell Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Natural Killer (NK) Cell Therapeutics market has been segmented into:
Mogamulizumab
Lorvotuzumab Mertansine
Others
By Application, Natural Killer (NK) Cell Therapeutics has been segmented into:
Cancer
Cardiovascular Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Natural Killer (NK) Cell Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Natural Killer (NK) Cell Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Natural Killer (NK) Cell Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Natural Killer (NK) Cell Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Natural Killer (NK) Cell Therapeutics Market Share Analysis
Natural Killer (NK) Cell Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Natural Killer (NK) Cell Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Natural Killer (NK) Cell Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Natural Killer (NK) Cell Therapeutics are:
Chipscreen Biosciences (China)
Bristol-Myers Squibb (USA)
Innate Pharma SA (France)
Affimed NV (Netherlands)
NantKwest Inc. (USA)
Altor BioScience Corporation (USA)
Sorrento Therapeutics Inc. (USA)
Takeda Pharmaceutical (Japan)
NKT Therapeutics (USA)
Table of Contents
1 Natural Killer (NK) Cell Therapeutics Market Overview
1.1 Product Overview and Scope of Natural Killer (NK) Cell Therapeutics
1.2 Classification of Natural Killer (NK) Cell Therapeutics by Type
1.2.1 Global Natural Killer (NK) Cell Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2019
1.2.3 Mogamulizumab
1.2.4 Lorvotuzumab Mertansine
1.2.5 Others
1.3 Global Natural Killer (NK) Cell Therapeutics Market by Application
1.3.1 Overview: Global Natural Killer (NK) Cell Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Global Natural Killer (NK) Cell Therapeutics Market by Regions
1.4.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Natural Killer (NK) Cell Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Natural Killer (NK) Cell Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Natural Killer (NK) Cell Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Natural Killer (NK) Cell Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Natural Killer (NK) Cell Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Natural Killer (NK) Cell Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Chipscreen Biosciences (China)
2.1.1 Chipscreen Biosciences (China) Details
2.1.2 Chipscreen Biosciences (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Chipscreen Biosciences (China) SWOT Analysis
2.1.4 Chipscreen Biosciences (China) Product and Services
2.1.5 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb (USA)
2.2.1 Bristol-Myers Squibb (USA) Details
2.2.2 Bristol-Myers Squibb (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb (USA) SWOT Analysis
2.2.4 Bristol-Myers Squibb (USA) Product and Services
2.2.5 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Innate Pharma SA (France)
2.3.1 Innate Pharma SA (France) Details
2.3.2 Innate Pharma SA (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Innate Pharma SA (France) SWOT Analysis
2.3.4 Innate Pharma SA (France) Product and Services
2.3.5 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Affimed NV (Netherlands)
2.4.1 Affimed NV (Netherlands) Details
2.4.2 Affimed NV (Netherlands) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Affimed NV (Netherlands) SWOT Analysis
2.4.4 Affimed NV (Netherlands) Product and Services
2.4.5 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 NantKwest Inc. (USA)
2.5.1 NantKwest Inc. (USA) Details
2.5.2 NantKwest Inc. (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 NantKwest Inc. (USA) SWOT Analysis
2.5.4 NantKwest Inc. (USA) Product and Services
2.5.5 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Altor BioScience Corporation (USA)
2.6.1 Altor BioScience Corporation (USA) Details
2.6.2 Altor BioScience Corporation (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Altor BioScience Corporation (USA) SWOT Analysis
2.6.4 Altor BioScience Corporation (USA) Product and Services
2.6.5 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sorrento Therapeutics Inc. (USA)
2.7.1 Sorrento Therapeutics Inc. (USA) Details
2.7.2 Sorrento Therapeutics Inc. (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sorrento Therapeutics Inc. (USA) SWOT Analysis
2.7.4 Sorrento Therapeutics Inc. (USA) Product and Services
2.7.5 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Takeda Pharmaceutical (Japan)
2.8.1 Takeda Pharmaceutical (Japan) Details
2.8.2 Takeda Pharmaceutical (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Takeda Pharmaceutical (Japan) SWOT Analysis
2.8.4 Takeda Pharmaceutical (Japan) Product and Services
2.8.5 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 NKT Therapeutics (USA)
2.9.1 NKT Therapeutics (USA) Details
2.9.2 NKT Therapeutics (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 NKT Therapeutics (USA) SWOT Analysis
2.9.4 NKT Therapeutics (USA) Product and Services
2.9.5 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Natural Killer (NK) Cell Therapeutics Players Market Share
3.2.2 Top 10 Natural Killer (NK) Cell Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Regions
4.2 North America Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Natural Killer (NK) Cell Therapeutics Revenue by Countries
5.1 North America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2020)
5.2 USA Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Natural Killer (NK) Cell Therapeutics Revenue by Countries
6.1 Europe Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Countries
7.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2020)
7.2 China Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Natural Killer (NK) Cell Therapeutics Revenue by Countries
8.1 South America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Natural Killer (NK) Cell Therapeutics by Countries
9.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Type (2019-2024)
10.3 Mogamulizumab Revenue Growth Rate (2015-2025)
10.4 Lorvotuzumab Mertansine Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Natural Killer (NK) Cell Therapeutics Market Segment by Application
11.1 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Natural Killer (NK) Cell Therapeutics Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Cardiovascular Diseases Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Natural Killer (NK) Cell Therapeutics Market Size Forecast (2021-2025)
12.1 Global Natural Killer (NK) Cell Therapeutics Market Size Forecast (2021-2025)
12.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Natural Killer (NK) Cell Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Natural Killer (NK) Cell Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Chipscreen Biosciences (China) Corporate Information, Location and Competitors
Table 6. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Major Business
Table 7. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Chipscreen Biosciences (China) SWOT Analysis
Table 9. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 10. Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bristol-Myers Squibb (USA) Corporate Information, Location and Competitors
Table 12. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Major Business
Table 13. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Bristol-Myers Squibb (USA) SWOT Analysis
Table 15. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 16. Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Innate Pharma SA (France) Corporate Information, Location and Competitors
Table 18. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Major Business
Table 19. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Innate Pharma SA (France) SWOT Analysis
Table 21. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 22. Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Affimed NV (Netherlands) Corporate Information, Location and Competitors
Table 24. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Major Business
Table 25. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Affimed NV (Netherlands) SWOT Analysis
Table 27. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 28. Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. NantKwest Inc. (USA) Corporate Information, Location and Competitors
Table 30. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Major Business
Table 31. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. NantKwest Inc. (USA) SWOT Analysis
Table 33. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 34. NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Altor BioScience Corporation (USA) Corporate Information, Location and Competitors
Table 36. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Major Business
Table 37. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Altor BioScience Corporation (USA) SWOT Analysis
Table 39. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 40. Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sorrento Therapeutics Inc. (USA) Corporate Information, Location and Competitors
Table 42. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Major Business
Table 43. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Sorrento Therapeutics Inc. (USA) SWOT Analysis
Table 45. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 46. Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Takeda Pharmaceutical (Japan) Corporate Information, Location and Competitors
Table 48. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Major Business
Table 49. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Takeda Pharmaceutical (Japan) SWOT Analysis
Table 51. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 52. Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. NKT Therapeutics (USA) Corporate Information, Location and Competitors
Table 54. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Major Business
Table 55. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. NKT Therapeutics (USA) SWOT Analysis
Table 57. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 58. NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 60. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players (2015-2020)
Table 61. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Regions (2015-2020)
Table 63. North America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2020)
Table 64. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Table 65. Europe Natural Killer (NK) Cell Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Natural Killer (NK) Cell Therapeutics Revenue by Countries (2015-2020)
Table 68. South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Table 71. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 72. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type (2015-2020)
Table 73. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Type (2021-2025)
Table 74. Global Natural Killer (NK) Cell Therapeutics Revenue by Application (2015-2020)
Table 75. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application (2015-2020)
Table 76. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Application (2021-2025)
Table 77. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Natural Killer (NK) Cell Therapeutics Picture
Figure 2. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2019
Figure 3. Mogamulizumab Picture
Figure 4. Lorvotuzumab Mertansine Picture
Figure 5. Others Picture
Figure 6. Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application in 2019
Figure 7. Cancer Picture
Figure 8. Cardiovascular Diseases Picture
Figure 9. Others Picture
Figure 10. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2019
Figure 19. Global Top 10 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 23. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Regions in 2018
Figure 24. North America Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Europe Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. South America Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 30. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries in 2019
Figure 31. USA Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Canada Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries in 2019
Figure 36. Germany Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. UK Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. France Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Russia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Italy Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries in 2019
Figure 43. China Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Japan Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Korea Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. India Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 49. South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries in 2019
Figure 50. Brazil Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. UAE Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type (2015-2020)
Figure 59. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type in 2019
Figure 60. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Type (2021-2025)
Figure 61. Global Mogamulizumab Revenue Growth Rate (2015-2020)
Figure 62. Global Lorvotuzumab Mertansine Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application (2015-2020)
Figure 65. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application in 2019
Figure 66. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Application (2021-2025)
Figure 67. Global Cancer Revenue Growth Rate (2015-2020)
Figure 68. Global Cardiovascular Diseases Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Natural Killer (NK) Cell Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. South America Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Chipscreen Biosciences (China)
Bristol-Myers Squibb (USA)
Innate Pharma SA (France)
Affimed NV (Netherlands)
NantKwest Inc. (USA)
Altor BioScience Corporation (USA)
Sorrento Therapeutics Inc. (USA)
Takeda Pharmaceutical (Japan)
NKT Therapeutics (USA)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets